Incase folks haven't read this elegant post, please read up. This is the best carrot EVER. Millionaires will be made here. Get ready to write a book about how you bought an overlooked stock in the year 2020 and made a killing.
The time to truly fight HIV and Covid is upon us with this Merger of Enzolytics Inc and BioClonetics. PATENTS, Sector Connections and Ties, TONS Of EXPERIENCE, on and on!
BioClonetics said that because of the similar structures of HIV and COVID-19 and the efficacy of its Clone 3 antibody in fighting HIV, the company has been asked by the National Science Foundation @NSF to submit a funding application for development of a COVID-19 antibody. The company currently has applications pending with the NSF and the National Institutes of Health.
Remember, this was months ago. Betting they got PLENTY TO TELL IN THE NEAR TERM.
LET THIS SINK IN: BioClonetics FINAL stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic & has shown in initial in vitro testing 2 B Effective against More than 95% of ALL Strains & viral subtypes of HIV-1 against which it's been tested
BioClonetics INVITED by the National Science Foundation (NSF) 2 submit an application 4 funding 4 development of anti-SARS-Cov-2 monoclonal antibodies using its proprietary #Technology. Such application to the NSF & a corresponding application to the NIH R NOW PENDING
The Company is also looking to expand its Medical Advisory board with individuals that have direct experience taking medical products through the regulatory process and bringing them to market. Betting we do NOT have to look far for these Additions.
Hello, my name is Rich Krebs. I'm currently a Senior Principal Scientist with Zoetis. We are an animal health company who recently introduced the first animal health monoclonal antibody treatment. I'm a believer in the concept and I believe your company is able to accomplish it's goals. Richard Krebs Senior Principal Scientist in R&D for an animal health company.
INVESTOR IN BioClonetics!!!
Look up Zoetis!!
Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. Wikipedia Stock price: ZTS (NYSE) $160.87 +0.40 (+0.25%) Sep 18, 4:05 PM EDT - Disclaimer THIS GUY INVESTED IN BIOCLONETICS FOLKS! U THINK THIS COMPANY KNOWS WHO BIOCLONETICS IS NOW??!!! LOL! I DO!
1 MORE BIGGIE DD and TIES.
THE BUZZ ABOUT BIOCLONETICS IMMUNOTHERAPEUTICS
Despite effective anti-HIV retrovirals, clearance of HIV-1 remains a critical global health issue. We are excited to be part of your strong interdisciplinary team and you have our full support for successful advancement of your technology.
Magdalena Leszczyniecka, Ph.D., MBA CEO and Present, STC Biologics, Inc.
DD HER and Her Company!! Started at Novartis Pharmaceuticals
STC was founded in 2009 and its team brings expertise in biologics drug development and global regulatory approvals from Genentech, Novartis, Shire, EMD Serono, Lonza, Alexion and Merrimack.
She gained start up experience prior to STC working for venture capital firms: Flagship Ventures and Atlas Ventures. She has led the development of MM-121 and anti-HER3 antibody programs at Merrimack Pharmaceuticals.